Company to exhibit nerve repair technologies at Booth 205
ALACHUA, FL – September 16, 2014 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced that it will sponsor an educational forum at the American Society for Surgery of the Hand (ASSH) 2014 Annual Meeting, taking place September 18-20 at the John B. Hynes Convention Center in Boston, MA.
The event, entitled “Nerve Matters”, will focus on improving outcomes in surgical nerve repair, featuring a discussion by leading nerve repair experts on the latest science, research and innovative treatment approaches. Surgeon panelists will include Peter Evans, MD, PhD, Cleveland Clinic; John V. Ingari, MD, Johns Hopkins; and Bauback Safa, MD, MBA, FACS, The Buncke Clinic. It will be held on Friday, September 19 at the Convention Center in Room 208.
Karen Zaderej, President and Chief Executive Officer for AxoGen commented, “Surgeon education is vitally important given the vast amount of new research and our deeper level of understanding in recent years of techniques for improving outcomes in surgical repair of peripheral nerves. AxoGen is committed to supporting the surgical community by providing opportunities for peer-led forums on these best practices, and we are pleased to invite all surgeons attending ASSH to join this important session.”
In addition to sponsoring educational forums, AxoGen will be exhibiting its full portfolio of nerve repair and protection technologies and products at Booth 205 at the ASSH meeting.
About this Event
ASSH Forum 27: Panel Presentation: Nerve Matters
Friday, September 19; 7:00 – 8:00 a.m.
Panelists: Peter Evans MD, PhD, John V. Ingari MD and Bauback Safa MD, MBA, FACS
John B. Hynes Convention Center, Room 208
To Register, click here: http://www.axogeninc.com/axogen-sponsors-nerve-matters-panel-at-assh/
About AxoGen, Inc.
AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, the only off-the-shelf commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed worldwide exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.
Help employers find you! Check out all the jobs and post your resume.
